Sequence Browser (Q8N1L9-2)

Available Structures (Graph-View Mode)

UniProt (Ref Seq)
Displayed Structure
Experimental Tertiary/Complex (PDB:XRay/EM)
Experimental Tertiary/Complex (PDB:NMR)
Modelled Tertiary (Phyre)
If the whole structure is coloured grey in '3D Structure Viewer' panel, please click the icon - on the top left corner of the viewer.
(If nothing changes then 'Sequence ↔ Structure' mapping may be unavailable).
1
274

Isoforms (From UniProt)

Isoform
Remark
Ref
Q8N1L9-2  
VSP_025752
Q8N1L9-1
Click on Isoform of interest to be redirected to the corresponding page

3D Structure Viewer - JSMol  

3D Structure Display

By clicking on any PDB entry under the 'Available Structures' section, you can visualise in this panel, the 3D details about the protein, and also see information about it's interactions and mutations where available.

To analyse the structural impact of your missense variant:

  • Select the corresponding experimental/modelled structure from the "Available Structures" Panel.
  • Right-click on the target structure and download it.
  • Go to our web server Missense3D to analyse structural impact.

    • Go to Missense3D

Protein Information (From UniProt)

Protein:
Basic leucine zipper transcriptional factor ATF-like 2
Other Names:
Suppressor of AP-1 regulated by IFN
Primary Accession:
Q8N1L9
Other Accessions:
D9IC56, Q8NAF4, Q8NAL8, Q96EH4
Gene :
BATF2*
Organism :
Human
Entry Name :
BATF2_HUMAN
Length :
274
Mass (Da) :
29,398
Last modified :
01-Jan-2002
Version :
v1
Isoforms :
2 
Structures :
Experimental 0 | Phyre prediction 0
Function : Show Hide

AP-1 family transcription factor that controls the differentiation of lineage-specific cells in the immune system. Following infection, participates in the differentiation of CD8(+) thymic conventional dendritic cells in the immune system. Acts via the formation of a heterodimer with JUN family proteins that recognizes and binds DNA sequence 5'-TGA[CG]TCA-3' and regulates expression of target genes (By similarity). Selectively suppresses CYR61/CCN1 transcription and hence blocks the downstream cell proliferation signals produced by CYR61 and inhibits CYR61-induced anchorage-independent growth and invasion in several cancer types, such as breast cancer, malignant glioma and metastatic melanoma. Possibly acts by interfering with AP-1 binding to CYR61 promoter.